• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

轻度和高度不溶性基质体驱动肝纤维化图谱

Atlas of mildly and highly insoluble matrisome driving liver fibrosis.

作者信息

Zhang Wen, Zhang Ning, Wu Wenyue, Li Hong, You Hong, Chen Wei

机构信息

Liver Research Center, Beijing Friendship Hospital, Capital Medical University, Beijing, China.

State Key Lab of Digestive Health, Beijing Friendship Hospital, Capital Medical University, Beijing, China.

出版信息

Front Pharmacol. 2024 Sep 2;15:1435359. doi: 10.3389/fphar.2024.1435359. eCollection 2024.

DOI:10.3389/fphar.2024.1435359
PMID:39286627
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11403298/
Abstract

The excessive deposition and cross-linking of core matrisome components typically result in abnormal remodeling of the extracellular matrix (ECM), leading to increased liver stiffness and worsening liver fibrosis. Exploring the biochemical properties of the ECM scaffold can deepen our understanding of the pathological mechanisms driving liver fibrosis and potentially facilitate the identification of therapeutic targets. While traditional sodium dodecyl sulfate (SDS)-based liver decellularization followed by proteomics can uncover the matrisome components within the ECM scaffold, it lacks the ability to reveal physicochemical characteristics like solubility. In our present study, using adult mouse liver as an example, we introduced a novel two-step workflow that combines our previously enhanced SDS (ESDS) decellularization with the conventional SDS method, enabling the identification of matrisome members with mild and/or high solubilities. Through this approach, we visualized the atlas of the mildly and highly insoluble matrisome contents in the adult mouse liver, as well as the regulatory network of highly insoluble matrisome that largely governs liver stiffness. Given the strong correlation between increased matrisome insolubility and heightened ECM stiffness, we believe that this methodology holds promise for future research focused on liver stiffness.

摘要

核心基质组分组分的过度沉积和交联通常会导致细胞外基质(ECM)异常重塑,进而导致肝脏硬度增加和肝纤维化加重。探索ECM支架的生化特性可以加深我们对驱动肝纤维化的病理机制的理解,并可能有助于确定治疗靶点。虽然传统的基于十二烷基硫酸钠(SDS)的肝脏去细胞化处理后进行蛋白质组学分析可以揭示ECM支架内的基质组成分,但它缺乏揭示诸如溶解度等物理化学特性的能力。在我们目前的研究中,以成年小鼠肝脏为例我们引入了一种新颖的两步工作流程,该流程将我们之前改进的SDS(ESDS)去细胞化方法与传统的SDS方法相结合,能够鉴定出具有轻度和/或高溶解度的基质组成员。通过这种方法,我们可视化了成年小鼠肝脏中轻度和高度不溶性基质组成分的图谱,以及在很大程度上控制肝脏硬度的高度不溶性基质组的调控网络。鉴于基质组不溶性增加与ECM硬度升高之间存在很强的相关性,我们相信这种方法对未来聚焦于肝脏硬度的研究具有前景。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7e8c/11403298/1c31b856d3cf/fphar-15-1435359-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7e8c/11403298/5776c34c9003/fphar-15-1435359-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7e8c/11403298/0b66ec12e0ae/fphar-15-1435359-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7e8c/11403298/1c31b856d3cf/fphar-15-1435359-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7e8c/11403298/5776c34c9003/fphar-15-1435359-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7e8c/11403298/0b66ec12e0ae/fphar-15-1435359-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7e8c/11403298/1c31b856d3cf/fphar-15-1435359-g003.jpg

相似文献

1
Atlas of mildly and highly insoluble matrisome driving liver fibrosis.轻度和高度不溶性基质体驱动肝纤维化图谱
Front Pharmacol. 2024 Sep 2;15:1435359. doi: 10.3389/fphar.2024.1435359. eCollection 2024.
2
Pipeline for precise insoluble matrisome coverage in tissue extracellular matrices.用于精确覆盖组织细胞外基质中不溶性基质组的流程。
Front Bioeng Biotechnol. 2023 May 22;11:1135936. doi: 10.3389/fbioe.2023.1135936. eCollection 2023.
3
Benefits and limits of decellularization on mass-spectrometry-based extracellular matrix proteome analysis of mouse kidney.脱细胞化对基于质谱的小鼠肾脏细胞外基质蛋白质组分析的益处和限制。
Proteomics. 2024 Sep;24(17):e2400052. doi: 10.1002/pmic.202400052. Epub 2024 Jun 19.
4
Comparison of extracellular matrix enrichment protocols for the improved characterization of the skin matrisome by mass spectrometry.比较细胞外基质富集方案,以通过质谱法提高皮肤基质体的特征描述。
J Proteomics. 2022 Jan 16;251:104397. doi: 10.1016/j.jprot.2021.104397. Epub 2021 Oct 20.
5
SWATH mass spectrometry as a tool for quantitative profiling of the matrisome.SWATH 质谱分析作为基质组定量分析的工具。
J Proteomics. 2018 Oct 30;189:11-22. doi: 10.1016/j.jprot.2018.02.026. Epub 2018 Mar 1.
6
Proteomics analysis of the matrisome from MC38 experimental mouse liver metastases.从 MC38 实验性小鼠肝转移模型中分析基质组
Am J Physiol Gastrointest Liver Physiol. 2019 Nov 1;317(5):G625-G639. doi: 10.1152/ajpgi.00014.2019. Epub 2019 Sep 23.
7
Texas 3-step decellularization protocol: looking at the cardiac extracellular matrix.德克萨斯三步去细胞化方案:观察心脏细胞外基质。
J Proteomics. 2013 Jun 28;86:43-52. doi: 10.1016/j.jprot.2013.05.004. Epub 2013 May 14.
8
Proteomic analysis of decellularized mice liver and kidney extracellular matrices.脱细胞小鼠肝脏和肾脏细胞外基质的蛋白质组学分析。
J Biol Eng. 2024 Feb 22;18(1):17. doi: 10.1186/s13036-024-00413-8.
9
Comparative proteomic assessment of matrisome enrichment methodologies.基质组富集方法的比较蛋白质组学评估
Biochem J. 2016 Nov 1;473(21):3979-3995. doi: 10.1042/BCJ20160686. Epub 2016 Sep 2.
10
The liver matrisome - looking beyond collagens.肝脏基质组——超越胶原蛋白的研究
JHEP Rep. 2020 Apr 18;2(4):100115. doi: 10.1016/j.jhepr.2020.100115. eCollection 2020 Aug.

引用本文的文献

1
Challenges of modelling of liver fibrosis.肝纤维化建模的挑战。
Front Cell Dev Biol. 2025 Apr 30;13:1567916. doi: 10.3389/fcell.2025.1567916. eCollection 2025.

本文引用的文献

1
Modulating extracellular matrix stiffness: a strategic approach to boost cancer immunotherapy.调节细胞外基质硬度:增强癌症免疫疗法的策略性方法。
Cell Death Dis. 2024 May 1;15(5):307. doi: 10.1038/s41419-024-06697-4.
2
Crosstalk of lysyl oxidase-like 1 and lysyl oxidase prolongs their half-lives and regulates liver fibrosis through Notch signal.赖氨酰氧化酶样蛋白1与赖氨酰氧化酶的相互作用延长了它们的半衰期,并通过Notch信号调节肝纤维化。
Hepatol Commun. 2024 Mar 11;8(4). doi: 10.1097/HC9.0000000000000391. eCollection 2024 Apr 1.
3
Liver Stiffness Measurement and Risk Prediction of Hepatocellular Carcinoma After HCV Eradication in Veterans With Cirrhosis.
肝硬化退伍军人 HCV 清除后肝硬度测量与肝细胞癌风险预测。
Clin Gastroenterol Hepatol. 2024 Apr;22(4):778-788.e7. doi: 10.1016/j.cgh.2023.11.020. Epub 2023 Dec 5.
4
Regression of Liver Fibrosis in Patients on Hepatitis B Therapy Is Associated With Decreased Liver-Related Events.乙肝治疗患者的肝纤维化消退与肝脏相关事件减少相关。
Clin Gastroenterol Hepatol. 2024 Mar;22(3):591-601.e3. doi: 10.1016/j.cgh.2023.11.017. Epub 2023 Nov 30.
5
Pipeline for precise insoluble matrisome coverage in tissue extracellular matrices.用于精确覆盖组织细胞外基质中不溶性基质组的流程。
Front Bioeng Biotechnol. 2023 May 22;11:1135936. doi: 10.3389/fbioe.2023.1135936. eCollection 2023.
6
Matrisome gene-based subclassification of patients with liver fibrosis identifies clinical and molecular heterogeneities.基于基质体基因的肝纤维化患者亚分类鉴定出临床和分子异质性。
Hepatology. 2023 Oct 1;78(4):1118-1132. doi: 10.1097/HEP.0000000000000423. Epub 2023 Apr 27.
7
MatrisomeDB 2.0: 2023 updates to the ECM-protein knowledge database.MatrisomeDB 2.0:2023 年 ECM-蛋白知识数据库更新。
Nucleic Acids Res. 2023 Jan 6;51(D1):D1519-D1530. doi: 10.1093/nar/gkac1009.
8
The Matrisome Genes From Hepatitis B-Related Hepatocellular Carcinoma Unveiled.揭示与乙型肝炎相关的肝细胞癌的基质体基因。
Hepatol Commun. 2021 Sep;5(9):1571-1585. doi: 10.1002/hep4.1741. Epub 2021 Jun 16.
9
Extracellular Matrix Remodeling in Chronic Liver Disease.慢性肝病中的细胞外基质重塑
Curr Tissue Microenviron Rep. 2021;2(3):41-52. doi: 10.1007/s43152-021-00030-3. Epub 2021 Jul 23.
10
A guide to the composition and functions of the extracellular matrix.细胞外基质的组成和功能指南。
FEBS J. 2021 Dec;288(24):6850-6912. doi: 10.1111/febs.15776. Epub 2021 Mar 23.